Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating robotic rehabilitation and nutrition for patients with soft tissue sarcoma

Official title: Soft Tissue Sarcoma: Instrumented Evaluation of Motor Performance and Impact of Robotic Rehabilitation, Nutrition and Quality of Life Assessment (START-RUN1)

Run by Fondazione Policlinico Universitario Campus Bio-Medico · NCT06873685 · Data updated 2026-11-12

This study is testing if personalized robotic rehabilitation and nutrition support can help people with localized soft tissue sarcoma recover better after surgery and improve their quality of life.

More Sarcoma, Soft Tissue trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorFondazione Policlinico Universitario Campus Bio-Medico
Academic / other
Drugs / interventionsradiation, chemotherapy
Locations3 sites (Rome, Lazio and 2 other locations)
StatusRecruiting
StartedMarch 13, 2025
Main results expectedDecember 31, 2025
Study endsAugust 31, 2026
Registry record updatedMarch 21, 2025
Trial IDNCT06873685 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with primary localized soft tissue sarcoma eligible for limb-sparing surgery.

Probably not a fit

Patients with recurrent tumors, metastatic disease, or those requiring palliative surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on patients with localized soft tissue sarcoma who are undergoing surgical treatment. It aims to assess motor impairments and the effectiveness of personalized robotic rehabilitation techniques on motor recovery. Additionally, the study evaluates the impact of surgery and rehabilitation on patients' quality of life and nutritional status through various assessments and questionnaires. The primary endpoint is to measure functional deficits and motor quality before and after rehabilitation.

Why it matters

Potential benefit: If successful, this study could significantly improve motor recovery and quality of life for patients recovering from soft tissue sarcoma surgery.

How similar studies have gone: While the approach of using robotic rehabilitation is innovative, similar studies have shown promise in improving rehabilitation outcomes for surgical patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. patient with primary and localized STS who is a candidate for limb-sparing surgery or retroperitoneal multivisceral resection (including partial or complete resection of the iliopsoas muscle with functional loss and potential femoral nerve involvement) with curative intent;
2. age 18 years or older.

Exclusion Criteria:

1. recurrent tumors;
2. metastatic disease;
3. candidate for palliative and non-radical surgery;
4. refusal to sign informed consent;
5. Pregnant or breastfeeding women at the time of screening.

Where it's running

  • Fondazione Policlinico Universitario Campus Bio-Medico
    Rome, Lazio, Italy
    Recruiting
  • Fondazione Don Carlo Gnocchi ONLUS
    Roma, Rm, Italy
    Active not recruiting
  • Istituto Nazionale Tumori-IRCCS-Fondazione G.Pascale
    Naples, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Deep phenotyping of walking problems after lower-limb orthopedic surgery in children treated for cancer

    We will use motion-capture labs and wearable sensors to see how walking problems develop and change over time in children and teens (ages 5–20) who have lower-limb orthopedic surgery for bone or soft tissue sarcoma or steroid-induced avascular necrosis, and compare them to healthy peers.

    Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07502885

  • Metformin plus standard first-line therapy for advanced soft tissue sarcoma

    This trial tests whether adding metformin to standard first-line systemic treatment helps people with previously untreated advanced or metastatic soft tissue sarcoma.

    Recruiting at 2 sites Phase 2 Wake Forest University Health Sciences · Charlotte, North Carolina and 1 other locations · NCT07291297

  • Short-course radiotherapy before surgery for soft tissue sarcoma

    This study tests whether a shorter course of radiation given before surgery (a 14 x 3 Gy schedule or an even shorter regimen) works as well and is safe for adults with intermediate- to high-grade soft tissue sarcoma.

    Recruiting at 2 sites The Netherlands Cancer Institute · Amsterdam and 5 other locations · NCT07071727

  • Assessing colorectal resections in patients with retroperitoneal sarcoma

    This study is trying to see how different surgical techniques for removing retroperitoneal sarcomas affect patients' recovery and quality of life.

    Recruiting at 16 sites Heidelberg University · Mannheim, Baden-Wurttemberg and 15 other locations · NCT06943612

  • Combining trabectedin with radiotherapy for treating soft tissue sarcoma

    This study is testing if combining a drug called trabectedin with radiotherapy can help people with different types of soft tissue sarcoma feel better and improve their treatment outcomes.

    Recruiting at 14 sites Phase 1/2 Grupo Espanol de Investigacion en Sarcomas · Bordeaux and 16 other locations · NCT02275286

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.